Viewing Study NCT02033551


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-02-25 @ 5:45 PM
Study NCT ID: NCT02033551
Status: COMPLETED
Last Update Posted: 2016-09-27
First Post: 2014-01-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Ovarian Cancer View
None Colon Cancer View
None Lung Cancer View
None Gastric Cancer View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastric Cancer View
None Lung Cancer View
None PARP Inhibitor View
None Ovarian Cancer View
None Solid Tumors View
None Breast Cancer View
None Colon Cancer View